Posted by Michael Wonder on 15 Dec 2020
FDA committee to meet again Thursday for Moderna's COVID-19 vaccine
14 December 2020 - A Food and Drug Administration advisory committee will meet for the second time in a week to discuss whether the regulator should authorise Moderna's MRNA, -1.19% COVID-19 vaccine candidate.
The same committee, the Vaccines and Related Biological Products Advisory Committee, met 10 December and voted 17-4-1 that the FDA should grant an emergency use authorisation to BioNTech and Pfizer's COVID-19 vaccine.
